Fiche centre
Royal Melbourne Hospital
Melbourne — Australia
Essais liés6clinical trials
VilleMelbournelocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05716100
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| zagociguat 15mg | Myopathies | Phase 2 | NCT06961344 | An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM) | TERMINATED |
| zagociguat 15mg | Accident vasculaire cérébral | Phase 2 | NCT06402123 | PRIZM — A Phase 2b Study of Zagociguat in Patients With MELAS | COMPLETED |
| ACTION-MS website - an 8-week cognitive behavioural therapy intervention for depression. | SEP | Non applicable | NCT07875309 | An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online | NOT_YET_RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05716100 | A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | RECRUITING |
| CAROL NSCLC treatment Device | Cancer | Non applicable | NCT07122258 | Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1 | RECRUITING |
| Early antibiotic cessation alert | Cancer | NA | NCT07051525 | ELSA-Adult — Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever | RECRUITING |